TICAGRELOR
| Brand name | BRILINTA |
|---|---|
| Active ingredient | TICAGRELOR |
| Strength | 60MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10300065*PED | July 2036 | — |
| 10300065 | January 2036 | use U-2542 |
| 8425934*PED | October 2030 | — |
| 8425934 | April 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.